{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29
  ],
  "modelUsed": "gemini-3-flash-preview",
  "studyDesignStructure": {
    "studyArms": [
      {
        "id": "arm_1",
        "name": "Open-label Induction Arm",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "All direct-entry subjects receive intranasal esketamine (56 mg or 84 mg) plus a new oral antidepressant.",
        "extensionAttributes": [
          {
            "url": "x-titration",
            "valueString": "true"
          },
          {
            "url": "x-doseEpochs",
            "valueString": "[{'dose': '56 mg', 'startDay': 1, 'endDay': 3, 'description': 'Starting dose'}, {'dose': '56 mg or 84 mg', 'startDay': 4, 'endDay': 28, 'description': 'Flexible dosing based on efficacy and tolerability'}]"
          }
        ]
      },
      {
        "id": "arm_2",
        "name": "Esketamine + Oral AD (Maintenance)",
        "type": {
          "code": "Experimental Arm",
          "codeSystem": "USDM",
          "decode": "Experimental Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects randomized to continue esketamine plus oral antidepressant during the maintenance phase."
      },
      {
        "id": "arm_3",
        "name": "Placebo + Oral AD (Maintenance)",
        "type": {
          "code": "Active Comparator Arm",
          "codeSystem": "USDM",
          "decode": "Active Comparator Arm"
        },
        "instanceType": "StudyArm",
        "description": "Subjects randomized to receive intranasal placebo plus oral antidepressant during the maintenance phase."
      }
    ],
    "studyCells": [
      {
        "id": "cell_1",
        "armId": "arm_1",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_1"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_2",
        "armId": "arm_1",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_2"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_3",
        "armId": "arm_1",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_3"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_4",
        "armId": "arm_1",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_4"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_5",
        "armId": "arm_1",
        "epochId": "epoch_5",
        "elementIds": [
          "elem_5"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_6",
        "armId": "arm_2",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_6"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_7",
        "armId": "arm_2",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_7"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_8",
        "armId": "arm_2",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_8"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_9",
        "armId": "arm_2",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_9"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_10",
        "armId": "arm_2",
        "epochId": "epoch_5",
        "elementIds": [
          "elem_10"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_11",
        "armId": "arm_3",
        "epochId": "epoch_1",
        "elementIds": [
          "elem_11"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_12",
        "armId": "arm_3",
        "epochId": "epoch_2",
        "elementIds": [
          "elem_12"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_13",
        "armId": "arm_3",
        "epochId": "epoch_3",
        "elementIds": [
          "elem_13"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_14",
        "armId": "arm_3",
        "epochId": "epoch_4",
        "elementIds": [
          "elem_14"
        ],
        "instanceType": "StudyCell"
      },
      {
        "id": "cell_15",
        "armId": "arm_3",
        "epochId": "epoch_5",
        "elementIds": [
          "elem_15"
        ],
        "instanceType": "StudyCell"
      }
    ],
    "studyCohorts": [
      {
        "id": "cohort_1",
        "name": "Direct-entry Subjects",
        "instanceType": "StudyCohort",
        "characteristic": "Subjects entering the study at the Screening/Prospective Observational Phase."
      },
      {
        "id": "cohort_2",
        "name": "Transferred-entry Subjects",
        "instanceType": "StudyCohort",
        "characteristic": "Subjects who completed the induction phase in Study ESKETINTRD3001 or ESKETINTRD3002."
      }
    ],
    "studyElements": [
      {
        "id": "elem_1",
        "name": "Open-label Induction Arm - Screening/Prospective Observational Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Open-label Induction Arm during Screening/Prospective Observational Phase"
      },
      {
        "id": "elem_2",
        "name": "Open-label Induction Arm - Open-label Induction Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Open-label Induction Arm during Open-label Induction Phase"
      },
      {
        "id": "elem_3",
        "name": "Open-label Induction Arm - Optimization Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Open-label Induction Arm during Optimization Phase"
      },
      {
        "id": "elem_4",
        "name": "Open-label Induction Arm - Maintenance Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Open-label Induction Arm during Maintenance Phase"
      },
      {
        "id": "elem_5",
        "name": "Open-label Induction Arm - Follow-up Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Open-label Induction Arm during Follow-up Phase"
      },
      {
        "id": "elem_6",
        "name": "Esketamine + Oral AD (Maintenance) - Screening/Prospective Observational Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Esketamine + Oral AD (Maintenance) during Screening/Prospective Observational Phase"
      },
      {
        "id": "elem_7",
        "name": "Esketamine + Oral AD (Maintenance) - Open-label Induction Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Esketamine + Oral AD (Maintenance) during Open-label Induction Phase"
      },
      {
        "id": "elem_8",
        "name": "Esketamine + Oral AD (Maintenance) - Optimization Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Esketamine + Oral AD (Maintenance) during Optimization Phase"
      },
      {
        "id": "elem_9",
        "name": "Esketamine + Oral AD (Maintenance) - Maintenance Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Esketamine + Oral AD (Maintenance) during Maintenance Phase"
      },
      {
        "id": "elem_10",
        "name": "Esketamine + Oral AD (Maintenance) - Follow-up Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Esketamine + Oral AD (Maintenance) during Follow-up Phase"
      },
      {
        "id": "elem_11",
        "name": "Placebo + Oral AD (Maintenance) - Screening/Prospective Observational Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo + Oral AD (Maintenance) during Screening/Prospective Observational Phase"
      },
      {
        "id": "elem_12",
        "name": "Placebo + Oral AD (Maintenance) - Open-label Induction Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo + Oral AD (Maintenance) during Open-label Induction Phase"
      },
      {
        "id": "elem_13",
        "name": "Placebo + Oral AD (Maintenance) - Optimization Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo + Oral AD (Maintenance) during Optimization Phase"
      },
      {
        "id": "elem_14",
        "name": "Placebo + Oral AD (Maintenance) - Maintenance Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo + Oral AD (Maintenance) during Maintenance Phase"
      },
      {
        "id": "elem_15",
        "name": "Placebo + Oral AD (Maintenance) - Follow-up Phase",
        "instanceType": "StudyElement",
        "description": "Treatment period for Placebo + Oral AD (Maintenance) during Follow-up Phase"
      }
    ],
    "summary": {
      "armCount": 3,
      "cellCount": 15,
      "cohortCount": 2,
      "elementCount": 15
    },
    "studyDesign": {
      "id": "sd_1",
      "name": "Study Design",
      "instanceType": "InterventionalStudyDesign",
      "trialIntentTypes": [
        {
          "code": "Treatment",
          "codeSystem": "USDM",
          "decode": "Treatment"
        },
        {
          "code": "Prevention",
          "codeSystem": "USDM",
          "decode": "Prevention"
        }
      ],
      "trialType": {
        "code": "Interventional",
        "codeSystem": "USDM",
        "decode": "Interventional"
      },
      "blindingSchema": {
        "code": "Double Blind",
        "codeSystem": "USDM",
        "decode": "Double Blind"
      },
      "maskedRoles": [
        "Subject",
        "Investigator"
      ],
      "randomizationType": {
        "code": "Randomized",
        "codeSystem": "USDM",
        "decode": "Randomized"
      },
      "controlType": {
        "code": "Active Control",
        "codeSystem": "USDM",
        "decode": "Active Control"
      },
      "armIds": [
        "arm_1",
        "arm_2",
        "arm_3"
      ],
      "cohortIds": [
        "cohort_1",
        "cohort_2"
      ],
      "therapeuticAreas": [
        "Psychiatry"
      ]
    }
  },
  "rawResponse": {
    "studyDesign": {
      "type": "Interventional",
      "trialIntentTypes": [
        "Treatment",
        "Prevention"
      ],
      "blinding": {
        "schema": "Double Blind",
        "maskedRoles": [
          "Subject",
          "Investigator"
        ]
      },
      "randomization": {
        "type": "Randomized",
        "allocationRatio": null,
        "stratificationFactors": []
      },
      "controlType": "Active Control",
      "therapeuticAreas": [
        "Psychiatry"
      ]
    },
    "arms": [
      {
        "name": "Open-label Induction Arm",
        "type": "Experimental Arm",
        "description": "All direct-entry subjects receive intranasal esketamine (56 mg or 84 mg) plus a new oral antidepressant.",
        "isTitration": true,
        "doseEpochs": [
          {
            "dose": "56 mg",
            "startDay": 1,
            "endDay": 3,
            "description": "Starting dose"
          },
          {
            "dose": "56 mg or 84 mg",
            "startDay": 4,
            "endDay": 28,
            "description": "Flexible dosing based on efficacy and tolerability"
          }
        ]
      },
      {
        "name": "Esketamine + Oral AD (Maintenance)",
        "type": "Experimental Arm",
        "description": "Subjects randomized to continue esketamine plus oral antidepressant during the maintenance phase.",
        "isTitration": false
      },
      {
        "name": "Placebo + Oral AD (Maintenance)",
        "type": "Active Comparator",
        "description": "Subjects randomized to receive intranasal placebo plus oral antidepressant during the maintenance phase.",
        "isTitration": false
      }
    ],
    "cohorts": [
      {
        "name": "Direct-entry Subjects",
        "characteristic": "Subjects entering the study at the Screening/Prospective Observational Phase."
      },
      {
        "name": "Transferred-entry Subjects",
        "characteristic": "Subjects who completed the induction phase in Study ESKETINTRD3001 or ESKETINTRD3002."
      }
    ],
    "epochs": [
      {
        "name": "Screening/Prospective Observational Phase",
        "description": "4-week phase to confirm non-response to current oral antidepressant."
      },
      {
        "name": "Open-label Induction Phase",
        "description": "4-week phase where subjects receive esketamine plus a new oral antidepressant."
      },
      {
        "name": "Optimization Phase",
        "description": "12-week phase to stabilize response/remission and determine dosing frequency."
      },
      {
        "name": "Maintenance Phase",
        "description": "Double-blind phase where stable remitters/responders are randomized to continue esketamine or switch to placebo."
      },
      {
        "name": "Follow-up Phase",
        "description": "Phase following the last dose of study medication."
      }
    ]
  }
}